Provided by Tiger Fintech (Singapore) Pte. Ltd.

Caribou Biosciences

1.26
+0.170015.60%
Post-market: 1.280.0200+1.59%19:54 EDT
Volume:2.03M
Turnover:2.53M
Market Cap:117.19M
PE:-0.78
High:1.33
Open:1.11
Low:1.11
Close:1.09
Loading ...

Precision BioSciences Reports Sharp Revenue Decline in Q1 2025 with Less Than $0.1M from Previous $17.6M

Reuters
·
15 May

Caribou Biosciences (CRBU) Receives a Hold from Evercore ISI

TIPRANKS
·
13 May

RBC Lowers Price Target on Caribou Biosciences to $10 From $11, Keeps Outperform, Speculative Risk

MT Newswires Live
·
09 May

Caribou Biosciences Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing

Reuters
·
09 May

Caribou Biosciences Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS
·
09 May

Caribou Biosciences Q1 EPS $(0.43) Beats $(0.44) Estimate, Sales $2.35M Beat $1.75M Estimate

Benzinga
·
09 May

Caribou Biosciences Inc: Reduced Its Workforce by Approximately 32% During Qtr

THOMSON REUTERS
·
09 May

BRIEF-Caribou Biosciences Q1 Basic EPS USD -0.43

Reuters
·
09 May

Caribou Biosciences Q1 Basic EPS USD -0.43

THOMSON REUTERS
·
09 May

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

Zacks
·
29 Apr

Caribou Biosciences price target lowered to $3 from $9 at H.C. Wainwright

TIPRANKS
·
28 Apr

Caribou Biosciences, Inc. : H.c. Wainwright Cuts Target Price to $3 From $9

THOMSON REUTERS
·
28 Apr

BUZZ-Caribou Biosciences rises on job cuts, shifts focus to cancer therapies

Reuters
·
25 Apr

BRIEF-Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Reuters
·
25 Apr

Caribou Biosciences Cuts Workforce, Shifts Pipeline to Focus on Key Oncology Programs

Dow Jones
·
25 Apr

Caribou Biosciences Inc - Changes Expected to Extend Cash Runway Into H2 2027

THOMSON REUTERS
·
25 Apr

Caribou Biosciences Announces Strategic Pipeline Prioritization With Focus on CB-010 and CB-011 Oncology Programs

THOMSON REUTERS
·
25 Apr

Caribou Biosciences Inc - to Reduce Workforce by 32%

THOMSON REUTERS
·
25 Apr

Caribou Biosciences Inc - Discontinues Gallop Phase 1 Trial of CB-010 for Lupus

THOMSON REUTERS
·
25 Apr

908 Devices Leads These 3 Penny Stocks To Consider

Simply Wall St.
·
10 Apr